Insider: HIGH SUSANNA GATTI Chief Operating Officer - Dyne Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 131,636 | 0 | 131,636 |
| Value | $1,655,980.88 | $0.00 | $1,655,980.88 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/18/2024 | DDS | 4,636 | Direct | COM | $34.41 | $159,524.76 | 131,636 |
| 09/18/2024 | DDS | 4,340 | Direct | COM | $34.41 | $149,339.40 | 136,272 |
| 09/11/2024 | DDS | 2,548 | Direct | COM | $31.89 | $81,255.72 | 143,334 |
| 09/11/2024 | DDS | 2,722 | Direct | COM | $31.89 | $86,804.58 | 140,612 |
| 08/19/2024 | DDS | 2,582 | Direct | COM | $45.01 | $116,215.82 | 146,210 |
| 08/19/2024 | DDS | 328 | Direct | COM | $46.00 | $15,088.00 | 145,882 |
| 06/24/2024 | DDS | 10,163 | Direct | COM | $35.33 | $359,058.79 | 148,792 |
| 06/21/2024 | DDS | 29,787 | Direct | COM | $35.01 | $1,042,842.87 | 148,792 |
| 06/12/2024 | DDS | 26,036 | Direct | COM | $33.17 | $863,614.12 | 162,756 |
| 06/12/2024 | DDS | 13,964 | Direct | COM | $33.70 | $470,586.80 | 148,792 |
| 06/11/2024 | DDS | 2,357 | Direct | COM | $31.23 | $73,609.11 | 151,705 |
| 06/11/2024 | DDS | 2,913 | Direct | COM | $31.23 | $90,972.99 | 148,792 |
| 06/10/2024 | DDS | 80,000 | Direct | COM | $30.24 | $2,419,200.00 | 154,062 |
| 05/16/2024 | DDS | 2,249 | Direct | COM | $28.20 | $63,421.80 | 154,551 |
| 05/16/2024 | DDS | 489 | Direct | COM | $28.59 | $13,980.51 | 154,062 |
| 03/11/2024 | DDS | 2,292 | Direct | COM | $25.70 | $58,904.40 | 156,800 |
| 03/08/2024 | DDS | 26,908 | Direct | COM | $26.66 | $717,367.28 | 159,383 |
| 03/08/2024 | DDS | 291 | Direct | COM | $27.41 | $7,976.31 | 159,092 |
| 03/07/2024 | DDS | 1,591 | Direct | COM | $25.85 | $41,127.35 | 186,291 |
| 12/11/2023 | DDS | 1,616 | Direct | COM | $10.72 | $17,323.52 | 187,882 |
| 11/02/2023 | DDS | 9,939 | Direct | COM | $7.40 | $73,548.60 | 94,605 |
| 09/18/2023 | DDS | 2,672 | Direct | COM | $9.41 | $25,143.52 | 104,544 |
| 09/12/2023 | DDS | 1,635 | Direct | COM | $10.41 | $17,020.35 | 107,216 |
| 06/13/2023 | DDS | 1,625 | Direct | COM | $12.43 | $20,198.75 | 108,851 |
| 03/14/2023 | DDS | 1,559 | Direct | COM | $13.33 | $20,781.47 | 110,476 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research